Last updated on September 5, 2025
Few health topics stir debate in Asia quite like the place of Traditional Chinese Medicine (TCM) next to Western biomedicine. The short answer to whether they can work together is: yes—in specific, evidence-supported ways. But integration only works with rigorous standards for safety, quality, and communication across both sides of care.
Below, we map where integration is already happening (pain and symptom relief), how modern science and technology are validating or refining TCM (AI, network pharmacology, DNA barcoding), and where red-flag risks (herb–drug interactions, contamination, and carcinogens like aristolochic acid) demand caution. We also zoom into Malaysia’s regulatory framework, which has quietly become one of ASEAN’s clearer roadmaps for integrative practice.
Editor’s note: This feature is informational and not a substitute for medical advice. Always discuss TCM use—especially herbs and supplements—with your clinician.
1) Where Integration Already Works: Pain & Symptom Relief
Acupuncture for back pain, osteoarthritis, migraine & cancer-related pain
- Back pain: The American College of Physicians recommends non-drug options—including acupuncture, massage, spinal manipulation, tai chi and yoga—as first-line for non-radicular low back pain, adding drugs only if non-drug care fails.
- Osteoarthritis: The American College of Rheumatology/Arthritis Foundation guideline conditionally recommends acupuncture for knee, hip and hand OA as part of multimodal care.
- Migraine prevention: A Cochrane review finds acupuncture reduces migraine frequency and can be at least non-inferior to several prophylactic drugs in some trials.
- Oncology pain: 2022 joint guidelines from the Society for Integrative Oncology and ASCO recommend acupuncture for aromatase-inhibitor–related joint pain and support acupuncture/reflexology/acupressure for general or musculoskeletal cancer pain.
Takeaway: In pain care, acupuncture is one of the best-studied TCM modalities with guideline-level endorsements—especially when it complements, not replaces, standard therapy.
Mind–body TCM: Tai chi & qigong
- Knee osteoarthritis & mobility: RCTs and meta-analyses suggest tai chi improves pain and function in KOA; effects are modest to moderate and method quality varies.
- Chronic low back pain, balance, fatigue: Reviews indicate tai chi and qigong can help with pain, balance and fatigue, with low adverse-event rates—again with heterogeneity in trials.
- NCCIH summary: U.S. NIH notes potential benefits of acupuncture for back/neck/OA pain and mind–body approaches for chronic pain conditions.
2) Where Modern Tech Is Changing TCM
AI & network pharmacology
Researchers use network pharmacology and AI to map multi-compound, multi-target actions of herbal formulas—linking phytochemicals to disease pathways and accelerating hypothesis generation for drug discovery. Reviews in 2024–2025 outline rising use of big databases (TCMSP, PubChem, GeneCards, ETCM) and even large language models (LLMs) to design and prioritize experiments.
Quality control: DNA barcoding & chemical fingerprinting
Authenticating the right species and detecting adulteration are critical. DNA barcoding and metabarcoding now verify multi-herb formulas; HPLC/UPLC fingerprinting standardizes batches and flags quality issues. Recent studies show barcoding catching off-label species in classical formulas; method reviews detail how orthogonal testing (DNA + chemistry) underpins modern QC.
Real-world pharmacovigilance
China’s Good Pharmacovigilance Practice and evolving safety systems seek to track adverse events across the life-cycle of herbal products, an essential step for global confidence in TCM.

3) Drugs & Medications: From TCM to Modern Medicines
- TCM-inspired success story: Artemisinin, discovered by Tu Youyou from the herb Artemisia annua, transformed malaria treatment and won the 2015 Nobel Prize in Physiology or Medicine—proof that careful extraction and clinical validation can turn traditional insights into world-changing medicines.
- Chinese patent medicines in trials: Formulas like Lianhua Qingwen have RCTs as add-on therapy for viral respiratory illness; meta-analyses signal symptomatic benefits, though trial quality and generalizability beyond China remain concerns—more high-quality, placebo-controlled, multicountry trials are needed.
Bottom line: Traditional knowledge can seed discovery, but each product needs modern-grade evidence, dosing standards and pharmacovigilance—exactly as with pharmaceuticals.
4) What the World Health Organization & ICD-11 Say
- WHO Traditional Medicine Global Summit (2023): WHO has prioritized building the evidence base and integrating traditional, complementary and integrative medicine (TCIM) into primary care where appropriate.
- ICD-11 integration: A Supplementary Chapter in ICD-11 allows optional coding of Traditional Medicine conditions (Module 1)—largely those with roots in ancient China—so health systems can capture usage and outcomes alongside conventional diagnoses.
5) Malaysia as a Case Study: Guardrails for Integrative Care
Malaysia’s Ministry of Health has spent two decades building a regulated integrative ecosystem:
- Law & registration: The Traditional and Complementary Medicine Act 2016 (Act 775) introduced statutory registration and regulation of practitioners, with penalties for unregistered practice.
- Public hospitals: MoH integrated hospitals offer selected services—acupuncture, traditional massage, and herbal therapy as an adjunct to cancer care—for specific indications under Schedule 2.
- Policy evolution: The National Policy envisions T&CM optimally integrated into the health system; research documents Malaysia’s staged move from self-regulation to statutory registration (with enforcement timelines through 2024).
Why it matters: Integration can be done—if it’s bounded by licensure, indications, and surveillance.

6) Safety First: The Non-Negotiables
Herb–drug interactions
- Anticoagulants & antiplatelets: Ginkgo biloba with warfarin/antiplatelets may raise bleeding risk in some observational data; results are mixed but caution is prudent. Goji (Lycium) berries and ginseng have case reports/reviews of interactions with warfarin or cardiovascular drugs. Always disclose supplements to your doctor.
- Licorice (Gan Cao): Can raise blood pressure, cause hypokalemia and pseudo-aldosteronism; monitor or avoid with hypertension/heart disease unless medically supervised.
Contamination & inherently toxic compounds
- Heavy metals: Reviews show non-trivial rates of lead/arsenic/mercury exceedances in herbal products; rigorous sourcing and QC are essential.
- Aristolochic acid (AA): Linked to kidney failure and urothelial cancers; multiple regulators (e.g., U.S. FDA) flag AA-containing botanicals for detention/warning. Avoid products containing AA or Aristolochia species.
- Herb-induced liver injury: Case series and reviews document hepatotoxicity with certain herbs and formulations; pharmacovigilance and liver-function monitoring are warranted when risk is plausible.
7) Practical Playbook: How to Combine TCM with Western Care—Safely
- Use licensed practitioners and disclosed products only; in Malaysia, verify TCM practitioner registration under Act 775.
- Tell every clinician (GP, oncologist, cardiologist, pharmacist) about every herb, tea, powder and supplement you take. Interaction risk rises with warfarin/antiplatelets, chemo, immunosuppressants and cardiovascular drugs.
- Prefer evidence-backed modalities: acupuncture for chronic back pain/OA/migraine prevention; tai chi/qigong for mobility, balance and symptom relief—as adjuncts, not replacements.
- Avoid injections of herbal products outside regulated settings; adverse event profiles are less well characterized.
- Demand quality: look for DNA barcoding/chemical fingerprinting, GMP/Pharmacopoeia compliance, and transparent sourcing for multi-herb formulas.
- Monitor labs if you add herbs while on narrow-therapeutic-index drugs (e.g., INR with warfarin).

8) So…Can TCM and Western Medicine Work Together?
**Yes—**and the best outcomes occur when:
- The modality has guideline-level or systematic-review support (e.g., acupuncture for several pain indications).
- The product is authenticated, standardized and tracked with modern QC and pharmacovigilance tools.
- Care is coordinated and transparent between patient, TCM practitioner and biomedical team—ideally within a regulatory framework like Malaysia’s Act 775 and MOH integrated hospital model.
Integration isn’t a compromise—it’s a discipline. When we combine ancient insights with modern methods, we can expand options for symptom control and discovery—without trading away safety or science. The story of artemisinin shows the upside; vigilance about AA, heavy metals and interactions shows the cost of cutting corners.
Disclaimer: This article is provided solely for general reference and reading purposes. It does not constitute medical advice, diagnosis, or treatment, and should not be relied upon as such. Readers are strongly advised to consult qualified healthcare professionals before making any decisions regarding medical conditions, treatments, or the use of traditional or complementary therapies. The Ledger Asia and its contributors assume no responsibility or liability for any consequences arising directly or indirectly from the use of the information contained herein.













